Table 2.
Outcomes of the placebo and 2% chlorhexidine/toothbrushing groups
| Variables | Placebo N(%) | Chlorhexidine N(%) | p value | |
| VAP rate | 11(45.8) | 18(64.3) | 0.29 | |
| Microbiologically confirmed VAP rate | 8(72.7) | 12(66.6) | 0.86 | |
| Duration of intubation (days) | 6 [4-12.7] | 8.5 [7.3-14.7] | 0.17 | |
| Duration of intubation | ||||
| Between 3 and 5 days | 12(50) | 5(17.8) | 0.03 | |
| Between 6 and 10 days | 5(20.8) | 14(50.0) | 0.06 | |
| >10 days | 9(29.2) | 7(32.2) | 0.94 | |
| Duration of ICU stay (days) | 11 [5-16] | 12 [9-29] | 0.36 | |
| Duration of hospital stay (days) | 17 [11-23] | 19 [9-34] | 0.62 | |
| Mortality rate | 9(37.5) | 13(46.5) | 0.07 | |
VAP - ventilator-associated pneumonia; ICU - Intensive care unit. Results are expressed as the number (%) or median [25%-75%].